Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

CD22 Exon 12 deletion is a characteristic genetic defect of therapy-refractory clones in paediatric acute lymphoblastic leukaemia.

Ma H, Qazi S, Ozer Z, Gaynon P, Reaman GH, Uckun FM.

Br J Haematol. 2012 Jan;156(1):89-98. doi: 10.1111/j.1365-2141.2011.08901.x. Epub 2011 Oct 21.

PMID:
22017452
[PubMed - indexed for MEDLINE]
2.

CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia.

Uckun FM, Goodman P, Ma H, Dibirdik I, Qazi S.

Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16852-7. doi: 10.1073/pnas.1007896107. Epub 2010 Sep 14.

PMID:
20841423
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.

Beesley AH, Cummings AJ, Freitas JR, Hoffmann K, Firth MJ, Ford J, de Klerk NH, Kees UR.

Br J Haematol. 2005 Nov;131(4):447-56.

PMID:
16281934
[PubMed - indexed for MEDLINE]
4.

CD22ΔE12 as a molecular target for corrective repair using RNA trans-splicing: anti-leukemic activity of a rationally designed RNA trans-splicing molecule.

Uckun FM, Qazi S, Ma H, Reaman GH, Mitchell LG.

Integr Biol (Camb). 2015 Feb 10;7(2):237-49. doi: 10.1039/c4ib00221k.

PMID:
25567759
[PubMed - in process]
5.

Defective expression of Bruton's tyrosine kinase in acute lymphoblastic leukemia.

Goodman PA, Wood CM, Vassilev AO, Mao C, Uckun FM.

Leuk Lymphoma. 2003 Jun;44(6):1011-8.

PMID:
12854903
[PubMed - indexed for MEDLINE]
6.

TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group.

Seeger K, Adams HP, Buchwald D, Beyermann B, Kremens B, Niemeyer C, Ritter J, Schwabe D, Harms D, Schrappe M, Henze G.

Blood. 1998 Mar 1;91(5):1716-22.

PMID:
9473238
[PubMed - indexed for MEDLINE]
Free Article
7.

Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.

Uckun FM, Stork L, Seibel N, Sarquis M, Bedros C, Sather H, Sensel M, Reaman GH, Gaynon PS.

Clin Cancer Res. 2000 Aug;6(8):3123-30.

PMID:
10955793
[PubMed - indexed for MEDLINE]
Free Article
8.

Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index.

Hoffmann K, Firth MJ, Beesley AH, Freitas JR, Ford J, Senanayake S, de Klerk NH, Baker DL, Kees UR.

Br J Haematol. 2008 Mar;140(6):656-64. doi: 10.1111/j.1365-2141.2008.06981.x.

PMID:
18302714
[PubMed - indexed for MEDLINE]
9.

Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia.

Gottardo NG, Hoffmann K, Beesley AH, Freitas JR, Firth MJ, Perera KU, de Klerk NH, Baker DL, Kees UR.

Br J Haematol. 2007 May;137(4):319-28.

PMID:
17456054
[PubMed - indexed for MEDLINE]
10.

CD22ΔE12 as a molecular target for RNAi therapy.

Uckun FM, Ma H, Cheng J, Myers DE, Qazi S.

Br J Haematol. 2015 Feb 6. doi: 10.1111/bjh.13306. [Epub ahead of print]

PMID:
25659406
[PubMed - as supplied by publisher]
11.

Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.

Sun L, Goodman PA, Wood CM, Crotty ML, Sensel M, Sather H, Navara C, Nachman J, Steinherz PG, Gaynon PS, Seibel N, Vassilev A, Juran BD, Reaman GH, Uckun FM.

J Clin Oncol. 1999 Dec;17(12):3753-66.

PMID:
10577847
[PubMed - indexed for MEDLINE]
12.
13.

Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.

Wu S, Gessner R, von Stackelberg A, Kirchner R, Henze G, Seeger K.

Cancer. 2005 Mar 1;103(5):1054-63.

PMID:
15651075
[PubMed - indexed for MEDLINE]
Free Article
14.

Analysis of p16 gene mutations and deletions in childhood acute lymphoblastic leukemias.

Lemos JA, Defavery R, Scrideli CA, Tone LG.

Sao Paulo Med J. 2003 Mar 5;121(2):58-62. Epub 2003 Jul 14.

PMID:
12870051
[PubMed - indexed for MEDLINE]
Free Article
15.

Clinical features and outcome of children with first marrow relapse of acute lymphoblastic leukemia expressing BCR-ABL fusion transcripts. BFM Relapse Study Group.

Beyermann B, Agthe AG, Adams HP, Seeger K, Linderkamp C, Goetze G, Ludwig WD, Henze G.

Blood. 1996 Feb 15;87(4):1532-8.

PMID:
8608244
[PubMed - indexed for MEDLINE]
Free Article
16.

Validation by RQ-PCR and flow cytometry of alpha-defensin1-3 (DEFA1-3) overexpression in relapsed and refractory acute lymphoblastic leukemia.

Te Kronnie G, Bicciato S, Franceschini L, Accordi B, Dellíorto MC, Rinaldi A, Pession A, Barisone E, Conter V, Locatelli F, Basso G.

Oncol Rep. 2006 Feb;15(2):341-6.

PMID:
16391852
[PubMed - indexed for MEDLINE]
17.

Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia.

Moreno DA, Scrideli CA, Cortez MA, de Paula Queiroz R, Valera ET, da Silva Silveira V, Yunes JA, Brandalise SR, Tone LG.

Br J Haematol. 2010 Sep;150(6):665-73. doi: 10.1111/j.1365-2141.2010.08301.x.

PMID:
20636436
[PubMed - indexed for MEDLINE]
18.

[A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].

Wang L, Zhang LP, Li ZG, Cheng YF, Tian KG, Lu AD.

Zhonghua Er Ke Za Zhi. 2005 Mar;43(3):170-3. Chinese.

PMID:
15833185
[PubMed - indexed for MEDLINE]
19.

Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.

Zhu YM, Foroni L, McQuaker IG, Papaioannou M, Haynes A, Russell HH.

Br J Cancer. 1999 Mar;79(7-8):1151-7.

PMID:
10098750
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers.

Staal FJ, van der Burg M, Wessels LF, Barendregt BH, Baert MR, van den Burg CM, van Huffel C, Langerak AW, van der Velden VH, Reinders MJ, van Dongen JJ.

Leukemia. 2003 Jul;17(7):1324-32. Erratum in: Leukemia. 2004 May;18(5):1041.

PMID:
12835720
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk